A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Neoplasms
Interventions: DRUG: Atezolizumab|DRUG: Placebo|DRUG: Gemcitabine|DRUG: Capecitabine|DRUG: Carboplatin
Sponsor: Hoffmann-La Roche